Video Support Program For Families With a Parent Newly Diagnosed With Cancer
RATIONALE: A videotape support program may help families improve communication and coping skills when a parent is diagnosed with cancer.
PURPOSE: Randomized trial to study the effectiveness of a video support program for families who have a parent who has been newly diagnosed with cancer.
Psychosocial Effects of Cancer and Its Treatment
Procedure: psychosocial assessment and care
|Official Title:||We Can Cope: Family Support When A Parent Has Cancer|
|Study Start Date:||August 2000|
OBJECTIVES: I. Determine if families who participate in a video support program function better as a family in the areas of communication, togetherness, and overall increased ability to cope when a parent is newly diagnosed with cancer. II. Determine if participation in this program decreases stress-related illness in the well members of the family. III. Determine the safety of this program. IV. Determine patient/family and medical provider satisfaction with this program.
OUTLINE: This a randomized study. Adult parent participants and spouses undergo a baseline assessment over approximately 1 hour comprising completion of a self-assessment form followed by an interview. Families are then randomized to one of two arms. Arm I: Adult parent participants receive a video support program comprising 3 videotapes (parent tape, adolescent tape, and child tape) and a parent guidebook. The parents are encouraged to screen the videotapes and decide whether to have their child and/or adolescent view the program. Arm II: Adult parent participants receive no video support material. Families may view the video program after study completion. Adult parent participants in both arms complete follow-up assessments at 6 and 12 weeks. This clinical trial is being conducted at the locations listed below. If you are interested in this clinical trial but unable to visit these locations, please call #1-800-848-3895 ext. 226 and ask for more information about the We Can Cope study.
PROJECTED ACCRUAL: A total of 230 families will be accrued for this study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00020553
|United States, Maine|
|Maine Center for Cancer Medicine and Blood Disorders|
|Scarborough, Maine, United States, 04074|
|United States, Massachusetts|
|Newton, Massachusetts, United States, 02464-1594|
|United States, New York|
|Albert Einstein Comprehensive Cancer Center|
|Bronx, New York, United States, 10461|
|United States, North Carolina|
|Buddy Kemp Caring House|
|Charlotte, North Carolina, United States, 28207|
|United States, Texas|
|Baylor University Medical Center|
|Dallas, Texas, United States, 75246|
|Study Chair:||Jonas I. Bromberg||Inflexxion, Inc.|